Matches in SemOpenAlex for { <https://semopenalex.org/work/W2318408079> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2318408079 abstract "A major challenge for using siRNA as cancer therapeutics is the delivery to solid tumors, due to their unfavorable physicochemical properties (negative charges, large molecular size, and instability). Our laboratory has developed paclitaxel-loaded tumor-penetrating microparticles (TPM) for intraperitoneal therapy of peritoneal tumors (JPET, 327: 673-682, 2008). Embedded in the design of TPM is the tumor priming technology to promote nanomedicine delivery in solid tumors (JPET, 322:80-88, 2007). The goal of this study was to evaluate whether TPM can improve siRNA delivery and expression for treating solid tumors located in the peritoneal cavity. Nanoparticles containing survivin siRNA (siRNA-NP) were developed. Survivin, a major resistance factor, is selectively expressed in tumors and upregulated by various chemotherapeutic agents. The activity of paclitaxel (agent loaded in TPM) and siRNA was investigated in cultured cells using the clonogenic assay and the survivin level determined using western blotting. In vivo activity was evaluated in peritoneal pancreatic HS766T xenograft tumors; the pharmacodynamic endpoints were reduction of proliferation index (measured by Ki67 labeling), induction of apoptosis (measured by caspase 3 expression), prolongation of survival time, and survivin protein level (measured by immunohistochemical staining and quantitative image analysis using NIH ImageJ). The two negative controls were blank nanoparticles (without siRNA) and non-targeting siRNA. In cultured cells, siRNA-NP produced protein knockdown, decreased cell clonogenicity, and enhanced paclitaxel activity. However, siRNA-NP did not produce protein knockdown or antitumor activity in tumors grown in animals, indicating insufficient delivery in vivo. In contrast, when given in combination with TPM, siRNA-NP produced survivin knockdown and enhanced the antitumor activity of TPM. The results indicate that TPM treatment improves the delivery and transfection of siRNA in intraperitoneal tumors in vivo and suggest potential therapeutic utility of coadministered TPM and siRNA-NP combination. Supported in part by research grants R44CA103133 and R43CA134047 from NCI, DHHS. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 5407. doi:10.1158/1538-7445.AM2011-5407" @default.
- W2318408079 created "2016-06-24" @default.
- W2318408079 creator A5009808561 @default.
- W2318408079 creator A5041981587 @default.
- W2318408079 creator A5052083463 @default.
- W2318408079 creator A5075877965 @default.
- W2318408079 creator A5077645346 @default.
- W2318408079 creator A5080936191 @default.
- W2318408079 creator A5085031128 @default.
- W2318408079 date "2011-04-15" @default.
- W2318408079 modified "2023-09-27" @default.
- W2318408079 title "Abstract 5407: Tumor penetrating microparticles enhance siRNA delivery and expression in pancreatic cancer" @default.
- W2318408079 doi "https://doi.org/10.1158/1538-7445.am2011-5407" @default.
- W2318408079 hasPublicationYear "2011" @default.
- W2318408079 type Work @default.
- W2318408079 sameAs 2318408079 @default.
- W2318408079 citedByCount "0" @default.
- W2318408079 crossrefType "proceedings-article" @default.
- W2318408079 hasAuthorship W2318408079A5009808561 @default.
- W2318408079 hasAuthorship W2318408079A5041981587 @default.
- W2318408079 hasAuthorship W2318408079A5052083463 @default.
- W2318408079 hasAuthorship W2318408079A5075877965 @default.
- W2318408079 hasAuthorship W2318408079A5077645346 @default.
- W2318408079 hasAuthorship W2318408079A5080936191 @default.
- W2318408079 hasAuthorship W2318408079A5085031128 @default.
- W2318408079 hasConcept C104317684 @default.
- W2318408079 hasConcept C117262875 @default.
- W2318408079 hasConcept C121608353 @default.
- W2318408079 hasConcept C126322002 @default.
- W2318408079 hasConcept C150903083 @default.
- W2318408079 hasConcept C173396325 @default.
- W2318408079 hasConcept C185592680 @default.
- W2318408079 hasConcept C190283241 @default.
- W2318408079 hasConcept C207001950 @default.
- W2318408079 hasConcept C22615655 @default.
- W2318408079 hasConcept C2775975398 @default.
- W2318408079 hasConcept C2777292972 @default.
- W2318408079 hasConcept C2780210213 @default.
- W2318408079 hasConcept C502942594 @default.
- W2318408079 hasConcept C54009773 @default.
- W2318408079 hasConcept C55493867 @default.
- W2318408079 hasConcept C71924100 @default.
- W2318408079 hasConcept C86803240 @default.
- W2318408079 hasConceptScore W2318408079C104317684 @default.
- W2318408079 hasConceptScore W2318408079C117262875 @default.
- W2318408079 hasConceptScore W2318408079C121608353 @default.
- W2318408079 hasConceptScore W2318408079C126322002 @default.
- W2318408079 hasConceptScore W2318408079C150903083 @default.
- W2318408079 hasConceptScore W2318408079C173396325 @default.
- W2318408079 hasConceptScore W2318408079C185592680 @default.
- W2318408079 hasConceptScore W2318408079C190283241 @default.
- W2318408079 hasConceptScore W2318408079C207001950 @default.
- W2318408079 hasConceptScore W2318408079C22615655 @default.
- W2318408079 hasConceptScore W2318408079C2775975398 @default.
- W2318408079 hasConceptScore W2318408079C2777292972 @default.
- W2318408079 hasConceptScore W2318408079C2780210213 @default.
- W2318408079 hasConceptScore W2318408079C502942594 @default.
- W2318408079 hasConceptScore W2318408079C54009773 @default.
- W2318408079 hasConceptScore W2318408079C55493867 @default.
- W2318408079 hasConceptScore W2318408079C71924100 @default.
- W2318408079 hasConceptScore W2318408079C86803240 @default.
- W2318408079 hasLocation W23184080791 @default.
- W2318408079 hasOpenAccess W2318408079 @default.
- W2318408079 hasPrimaryLocation W23184080791 @default.
- W2318408079 hasRelatedWork W1146292633 @default.
- W2318408079 hasRelatedWork W1970660459 @default.
- W2318408079 hasRelatedWork W1996560526 @default.
- W2318408079 hasRelatedWork W2008344708 @default.
- W2318408079 hasRelatedWork W2075436268 @default.
- W2318408079 hasRelatedWork W2075727303 @default.
- W2318408079 hasRelatedWork W2076754526 @default.
- W2318408079 hasRelatedWork W2080744352 @default.
- W2318408079 hasRelatedWork W2330299153 @default.
- W2318408079 hasRelatedWork W2465971964 @default.
- W2318408079 hasRelatedWork W2566764832 @default.
- W2318408079 hasRelatedWork W2589884967 @default.
- W2318408079 hasRelatedWork W2603590280 @default.
- W2318408079 hasRelatedWork W2679347784 @default.
- W2318408079 hasRelatedWork W2796548286 @default.
- W2318408079 hasRelatedWork W2802121833 @default.
- W2318408079 hasRelatedWork W2902961488 @default.
- W2318408079 hasRelatedWork W2983556597 @default.
- W2318408079 hasRelatedWork W3127689354 @default.
- W2318408079 hasRelatedWork W2479441625 @default.
- W2318408079 isParatext "false" @default.
- W2318408079 isRetracted "false" @default.
- W2318408079 magId "2318408079" @default.
- W2318408079 workType "article" @default.